Reckitt Benckiser Group plc (RBGLY)
Market Cap | 42.72B |
Revenue (ttm) | 18.11B |
Net Income (ttm) | 1.95B |
Shares Out | n/a |
EPS (ttm) | 2.73 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | 0.47 (3.75%) |
Ex-Dividend Date | Aug 5, 2024 |
Volume | 35,159 |
Open | 11.90 |
Previous Close | 12.31 |
Day's Range | 11.88 - 12.05 |
52-Week Range | 10.24 - 15.03 |
Beta | 0.09 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Oct 25, 2024 |
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet bra... [Read more]
Financial Performance
In 2023, Reckitt Benckiser Group's revenue was 14.61 billion, an increase of 1.07% compared to the previous year's 14.45 billion. Earnings were 1.64 billion, a decrease of -29.48%.
Financial numbers in GBP Financial StatementsNews
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for ...
Reckitt Benckiser Group plc (RBGPF) Q3 2024 Earnings Call Transcript
Lysol Maker Reckitt Benckiser Beats Views as Easing Prices Draw Shoppers
Lysol maker Reckitt Benckiser’s revenue fell by less than expected in the third quarter as declines in sales volumes eased, and confirmed its targets for the full year.
Lysol Maker Reckitt Benckiser Beats Views as Easing Prices Draw Shoppers
Lysol maker Reckitt Benckiser's revenue fell by less than expected in the third quarter as declines in sales volumes eased, and confirmed its targets for the full year.
Reckitt Limits Sales Decline Amid US Baby Formula Lawsuits
Reckitt Benckiser Plc sales fell less than expected, offering limited relief for investors concerned about US lawsuits over its formula for premature babies.
Healthcare helps Reckitt beat quarterly sales estimates
Reckitt reported a smaller than expected fall in third-quarter underlying sales on Wednesday, helped by its health business, which makes Nurofen painkillers and Strepsils lozenges.
Three Quick Facts: Lloyds, Reckitt Benckiser, WPP
Lloyds impairments down & interest income stable, hit to Reckitt's nutrition sales less than expected, WPP notes gains in Q3
Reckitt Benckiser Is Still A 'Hold' Despite The New Strategy
Reckitt Benckiser reports mixed half-year results, with slight revenue growth and improved cash flow. New growth strategy in place. Read more here.
Abbott, Reckitt face trial over premature baby formula amid alarm from doctors
A Missouri mother and her lawyers this week will aim to convince a jury that Abbott , Reckitt's Mead Johnson and St. Louis Children's Hospital are responsible for a severe intestinal illness that she ...
Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula
European consumer giant Reckitt Benckiser Group Plc (OTC: RBGLY) (OTC: RBGPF) has reportedly kickstarted preliminary talks with potential buyers regarding the sale of its homecare division, which fe...
Reckitt Benckiser starts discussions on sale of Mead Johnson, Lysol assets - report
Reckitt initiates discussions on $7.9 billion homecare assets sale, Bloomberg reports
Reckitt Benckiser has initiated early discussions with potential suitors for a sale of its homecare assets, which could be worth over 6 billion pounds ($7.89 billion), Bloomberg News reported on Tuesd...
Reckitt Starts Talks on £6 Billion Homecare Assets Sale
Reckitt Benckiser Group Plc has started early discussions with some of the potential suitors for its homecare assets, which could fetch more than £6 billion ($7.9 billion) in a deal, according to peop...
TV advertising in news genre up in first half, driven by F&B
Television advertising in the news genre increased by 5% year-on-year during January-June, driven primarily by food and beverages. Cement emerged as the top category with Ultratech Cement leading. Hin...
10 High-Yield A-Rated Blue-Chips For Potentially Scary Times Ahead
The economy is stable but cooling, with the labor market showing signs of slowing down. GDP growth is likely to keep falling, and individual companies could suffer. Long-term investors should focus on...
Abbott Labs Stock Falls After Baby-Formula Ruling. Reckitt Benckiser Tumbles Too.
Shares of Abbott Laboratories and U.K.-listed Reckitt Benckiser both drop after a Missouri jury rules against the American healthcare company.
Baby-formula settlement drags Reckitt down after $495 million jury award against Abbott
U.K. consumer-products giant Reckitt saw its share price slump after a jury awarded $495 million in a key baby-formula case.
Abbott shares slide after trial verdict, weigh on rival Reckitt Benckiser
Abbott Laboratories' shares fell nearly 7% premarket, while British peer Reckitt Benckiser slumped 9% on Monday, after the U.S. healthcare firm was ordered to pay $495 million in damages related to it...
Reckitt Benckiser Group plc (RBGPF) Q2 2024 Earnings Call Transcript
Reckitt Benckiser Group plc (OTCPK:RBGPF) Q2 2024 Results Conference Call July 24, 2024 3:30 AM ET Company Participants Richard Joyce - Head of Investor Relations Kristoffer Licht - CEO & Executive Di...
Reckitt to simplify by dropping home products and troubled infant-formula unit
Reckitt Benckiser Group on Wednesday said it plans to refocus its business on its top-selling brands including Durex and Gaviscon by pulling away from its more troubled and less profitable segments in...
Reckitt to offload homecare brands, consider nutrition options
Reckitt Benckiser will consider options for its troubled nutrition business and offload a portfolio of homecare brands by the end of 2025, it said on Wednesday, planning to refocus on healthcare and h...
Reckitt's baby formula sales to suffer after tornado damages warehouse
Sales of Reckitt's Mead Johnson baby formula powder are likely to take a short-term hit after a tornado damaged a third-party warehouse in the United States, the British consumer goods company said on...
U.K. Top 40 Quality Dividend Stocks: Summer 2024
Unfortunately, UK investors have had to suffer weak or negative capital gains in recent years to get those high yields. The good news is that the UK remains an attractive market for dividend investors...
Top 3 undervalued U.K. stocks that are worth owning in June 2024
FTSE 100 is currently down about 3.5% versus its year-to-date high in last month. But there's a bunch of U.K. stocks that are trading at a much more attractive discount at writing.
Reckitt Benckiser: Attractive Price For Its Stable Of Brands (Rating Upgrade)
Reckitt, a consumer goods producer, has experienced a decline in share price due to concerns over its nutrition business and ongoing legal issues. Despite underwhelming business performance, Reckitt's...